Value of drug-eluting stents after failed percutaneous transluminal angioplasty in the infrapopliteal vessels for the treatment of critical limb ischemia: Favorable mid-term patency and limb salvage results

Journal of Cardiovascular Surgery

Volumn 52, Issue 4, 2011, Pages 461-466

  Lookstein, R A ^a   Ward, T J ^a   Kim, E ^a   Fischman, A M ^a   Nowakowksi, F S ^a   Ellozy, S ^a   Teodorescu, V ^a   Vouyouka, A G ^a   Faries, P L ^a   Weintraub, J L ^a  

^a MOUNT SINAI MEDICAL CENTER   (United States)

Author keywords

Drug eluting stents; Extremities; Ischemia

Indexed keywords

'TAXUS'; ACETYLSALICYLIC ACID; BOSTON SCIENTIFIC PROMUS; CLOPIDOGREL; CYPHER; EVEROLIMUS; HEPARIN; PACLITAXEL; RAPAMYCIN; UNCLASSIFIED DRUG;

ADULT; AGED; ANTICOAGULANT THERAPY; ARTERY OCCLUSION; ARTICLE; CLINICAL EFFECTIVENESS; COHORT ANALYSIS; COMPUTED TOMOGRAPHIC ANGIOGRAPHY; CRITICAL LIMB ISCHEMIA; DRUG DOSE TITRATION; DRUG ELUTING STENT; FEMALE; HUMAN; INFRAPOPLITEAL ARTERY STENOSIS; LEG AMPUTATION; LEG ISCHEMIA; LIMB ISCHEMIA; LIMB SALVAGE; MAJOR CLINICAL STUDY; MALE; MORTALITY; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; RETROSPECTIVE STUDY; TREATMENT FAILURE; VASCULAR PATENCY;

ARTERIAL OCCLUSIVE DISEASES; DIABETIC ANGIOPATHIES; ENDOVASCULAR PROCEDURES; FEMALE; HUMANS; ISCHEMIA; LOWER EXTREMITY; MALE; THROMBECTOMY; THROMBOLYTIC THERAPY; ULTRASONIC THERAPY;

EID: 80054734457     PISSN: 00219509     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Ostchega Y, Paulose-Ram R, Dillon CF, Gu Q, Hughes JP. Prevalence of peripheral arterial disease and risk factors in persons aged 60 and older: data from the National Health and Nutrition Examination Survey 1999-2004. J Am Geriatr Soc 2007;55:583-9. (Pubitemid 46496588)
2. Management of peripheral arterial disease (PAD). TransAtlantic Inter-Society Consensus (TASC). Eur J Vasc Endovasc Surg 2000;19(Suppl A):Si-xxviii. S1-250.
3. Rosamond W, Flegal K, Furie K, Go A, Greenlund K, Haase N et al. American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Heart disease and stroke statistics - 2008 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation 2008;117:e25-e146.
4. Adam DJ, Beard JD, Cleveland T, Bell J, Bradbury AW, Forbes JF et al. Bypass versus angioplasty in severe ischaemia of the leg (BASIL): multicentre, randomised controlled trial. Lancet 2005;366:1925-34. (Pubitemid 41713982)
5. Tsetis D, Belli AM. The role of infrapopliteal angioplasty. Br J Radiol. 2004;77:1007-15. (Pubitemid 40057797)
6. Söder HK, Manninen HI, Jaakkola P, Matsi PJ, Räsänen HT, Kaukanen E et al. Prospective trial of infrapopliteal artery balloon angioplasty for critical limb ischemia: angiographic and clinical results. J Vasc Interv Radiol 2000 11:1021-31.
7. Siablis D, Karnabatidis D, Katsanos K, Diamantopoulos A, Spiliopoulos S, Kagadis G et al. Infrapopliteal application of sirolimus-eluting versus bare metal stents for critical limb ischemia: analysis of long-term angiographic and clinical outcome. J Vasc Interv Radiol 2009;20:1141-50.
8. Aoki J, Colombo A, Dudek D, Banning AP, Drzewiecki J, Zmudka K et al. Peristent remodeling and neointimal suppression 2 years after polymer-based, paclitaxel-eluting stent implantation: insights from serial intravascular ultrasound analysis in the TAXUS II study. Circulation 2005;112:3876.
9. Stettler C, Wandel S, Allemann S, Kastrati A, Morice MC, Schömig A et al. Outcomes associated with drug-eluting and bare-metal stents: a collaborative network meta-analysis. Lancet 2007;370:937.
10. CYPHER® Stent Specifications [Internet]. Available from www.cypherstent.com/cypher-stent/specifications/pages/index.aspx [cited 2011, Jul 11].
11. Wang Q, Pierson W, Sood P, Bol C, Cannon L, Gordon P et al. Pharmacokinetic Sub-Study in the SPIRIT III Randomized and Controlled Trial of XIENCE V Everolimus Eluting Coronary Stent System. J Interv Cardiol 2010;23:26-32.
12. Grube E, Buellesfeld L. Paclitaxel eluting stents: current clinical experience. Am J Cardiovasc Drugs 2004;4:355-60. (Pubitemid 39642488)
13. Romiti M, Albers M, Brochado-Neto FC, Durazzo AE, Pereira CA, De Luccia N. Meta-analysis of infrapopliteal angioplasty for chronic critical limb ischemia. J Vasc Surg 2008;47:975-81.
14. Rosales OR, Mathewkutty S, Gnaim C. Drug eluting stents for below the knee lesions in patients with critical limb ischemia : long-term follow-up. Catheter Cardiovasc Interv 2008;72:112-5. (Pubitemid 352008995)
15. Feiring AJ, Wesolowski AA, Lade S. Primary stent-supported angioplasty for treatment of below-knee critical limb ischemia and severe claudication: early and one-year outcomes. J Am Coll Cardiol. 2004;44:2307-14. (Pubitemid 39647603)
16. Commeau P, Barragan P, Roquebert PO. Sirolimus for below the knee lesions: mid-term results of SiroBTK study. Catheter Cardiovasc Interv 2006;68:793-8. (Pubitemid 44721107)
17. Balzer JO, Zeller T, Rastan A, Sixt S, Vogl TJ, Lehnert T, Khan V. Percutaneous interventions below the knee in patients with critical limb ischemia using drug eluting stents. J Cardiovasc Surg (Torino) 2010;51:183-91.
18. Marston WA, Davies SW, B. Armstrong, M.A. Farber, R.C. Mendes and JJ. Fulton et al. Natural history of limbs with arterial insufficiency and chronic ulceration treated without revascularization. J Vasc Surg 2006;44:108-14.
19. Bosiers M. DESTINY trial-12 months clinical and angiographic findings. Leipzig, Germany. The Leipzig Interventional Course. January 19, 2011.
20. Scheinert, D. Achilles study- randomized comparison of Sirolimus eluting stents vs PTA for BTK obstructions. Leipzig, Germany. The Leipzig Interventional Course. January 19, 2011.
21. Katsanos K. Cost-effectiveness analysis of infrapopliteal drug-eluting stents for critical limb ischemia treatment. Chicago, Ill. Society of Interventional Radiology Annual Scientific Meeting.